Kygevvi

Active Ingredient(s): Doxecitine + Doxribtimine
FDA Approved: * November 3, 2025
Pharm Company: * UCB INC
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Kygevvi Oral Powder, for Solution
NDC: 50474-350
Labeler:
Ucb, Inc.